Our Platform has generated a strong pipeline of high value targets
Generating High
Value Targets
Policy on expanded access (EA) to investigational drugs
Currently, participation in clinical trials is the only way for patients to gain access to MOMA’s investigational therapies. As more clinical data on the safety and efficacy of these investigational therapies become available, we will review and update our policy on Expanded Access.